The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in man
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN
Mahgoub, A., Dring, L. G., Idle, J. R., Lancaster, R., & Smith, R. L. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91430-1 · Cited by 1,183
Defective N-oxidation of sparteine in man: A new pharmacogenetic defect
Eichelbaum, M., Spannbrucker, N., Steincke, B., & Dengler, H. J. (1979) · European Journal of Clinical Pharmacology · doi:10.1007/bf00562059 · Cited by 632
Evans, D. A., Mahgoub, A., Sloan, T. P., Idle, J. R., & Smith, R. L. (1980) · Journal of Medical Genetics · doi:10.1136/jmg.17.2.102 · Cited by 536
Ethnic Differences in Drug Metabolism
Kalow, W. (1982) · Clinical Pharmacokinetics · doi:10.2165/00003088-198207050-00001 · Cited by 220
Pharmacogenetics of Tolbutamide Metabolism in Humans
Scott, J., & Poffenbarger, P. L. (1978) · Diabetes · doi:10.2337/diab.28.1.41 · Cited by 179
Polymorphisms of Oxidation at Carbon Centers of Drugs and Their Clinical Significance
Idle, J. R., & Smith, R. L. (1979) · Drug Metabolism Reviews · doi:10.3109/03602537908993896 · Cited by 164
Multiple forms of cytochrome P-450 and the importance of molecular biology and evolution
Nebert, D. W., & Negishi, M. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90523-8 · Cited by 144
Nebert, D. W. (1979) · Molecular and Cellular Biochemistry · doi:10.1007/bf00849277 · Cited by 142
Pharmacogenetics of tolbutamide metabolism in humans
Scott, J., & Pl, P. (1979) · Diabetes · doi:10.2337/diabetes.28.1.41 · Cited by 139
Stereoselective metabolism of mephenytoin in man.
Kupfer, A., Roberts, R. K., Schenker, S., et al. (1981) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32651-0 · Cited by 76
Mephenytoin hydroxylation deficiency: Kinetics after repeated doses
Kupfer, A., Desmond, P. V., Patwardhan, R. V., et al. (1984) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1984.5 · Cited by 61
Kupfer, A., Desmond, P. V., Schenker, S., & Branch, R. A. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33105-8 · Cited by 52
Clinical pharmacology. Possible clinical importance of genetic differences in drug metabolism.
Nebert, D. W. (1981) · BMJ · doi:10.1136/bmj.283.6290.537 · Cited by 40
Stereoselectivity of the Arene Epoxide Pathway of Mephenytoin Hydroxylation in Man
Kupfer, A., Lawson, J. A., & Branch, R. A. (1984) · Epilepsia · doi:10.1111/j.1528-1157.1984.tb04148.x · Cited by 27
Cited by
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169
The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans.
de Morais, S. M., Wilkinson, G. R., Blaisdell, J., Nakamura, K., Meyer, U. A., & Goldstein, J. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40694-6 · Cited by 956
Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
Desta, Z., Zhao, X., Shin, J.-G., & Flockhart, D. A. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241120-00002 · Cited by 942
Guengerich, F. P. (1995) · Cytochrome P450 · doi:10.1007/978-1-4757-2391-5_14 · Cited by 728
Guengerich, F. P., Martin, M. V., Beaune, P. H., Kremers, P., Wolff, T., & Waxman, D. J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89213-x · Cited by 724
Metadata
- Authors
- K�pfer, A., & Preisig, R.
- Venue
- European Journal of Clinical Pharmacology
- Published
- 1984
- Volume
- 26
- Issue
- 6
- Pages
- 753-759
- ISSN
- 0031-6970 (ISSN-L)
- 1432-1041
- OpenAlex
- W1991163272
- Cited by
- 362
- References
- 14
- FWCI
- 10.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.